MYR 0.57
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 18.46 Million MYR | -30.1% |
2022 | 26.42 Million MYR | 39.17% |
2021 | 18.98 Million MYR | 119.23% |
2020 | 8.66 Million MYR | 161.87% |
2019 | 3.3 Million MYR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 6.36 Million MYR | 153.83% |
2024 Q1 | 2.5 Million MYR | -0.32% |
2023 Q2 | 6.87 Million MYR | 44.39% |
2023 Q4 | 2.51 Million MYR | -41.68% |
2023 Q1 | 4.76 Million MYR | -12.82% |
2023 FY | 18.46 Million MYR | -30.1% |
2023 Q3 | 4.31 Million MYR | -37.26% |
2022 Q3 | 9.51 Million MYR | 0.0% |
2022 FY | 26.42 Million MYR | 39.17% |
2022 Q4 | 5.46 Million MYR | -42.6% |
2021 FY | 18.98 Million MYR | 119.23% |
2020 FY | 8.66 Million MYR | 161.87% |
2019 FY | 3.3 Million MYR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Artroniq Berhad | -5.51 Million MYR | 434.869% |
Optimax Holdings Berhad | 12.89 Million MYR | -43.263% |
Pharmaniaga Berhad | -80.16 Million MYR | 123.039% |
Apex Healthcare Berhad | 397.98 Million MYR | 95.36% |